Association of Leptin Promoter 2548G/A variant with Serum Leptin, Lipid Profile and Type 2 Diabetes Mellitus
Main Article Content
Abstract
Background: A common 2548G/A promoter variant of the human leptin gene has been implicated in circulating leptin levels variations and pathogenesis of type 2 diabetes mellitus but available data are still conflicting.
Objective: To explore potential associations between LEP 2548G/A of leptin with T2DM and the effect of this variation on serum leptin levels.
Patients and Methods: Sixty two patients with T2DM and fifty non-diabetic controls were included in the study. Blood samples were collected from subjects for biochemical analysis and Genotyping was performed by polymerase chain reaction reaction–restriction fragment length polymorphism (PCR-RFLP).
Results: The genotype frequencies for LEP 2548G/G, LEP 2548G/A LEP 2548A/A were 46%, 32% and 22% in control group, and 19.4%, 33.9% and 46.7% in diabetic group, respectively. The A allele and GA/AA genotype of LEP 2548G/A was found to be more frequent than the G allele and GG genotype in T2DM patients compares to the controls. Subjects with the GA + AA genotype of LEP 2548G/A were at increased risk for T2DM (P=0.0001, OR = 1.78; 95% CI: 1.19–2.38). The serum leptin concentration of GA + AA genotype carriers was significantly higher from that of the GG genotype in the diabetic group.
Conclusion: A allele carrier who have higher serum concentrations of leptin may have an association with the risk of T2DM development in the Erbi population.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.